Does Noopept Help With Limited clinical evidence suggests Noopept (20 mg/day for...?

Evidence Summary

Limited clinical evidence suggests Noopept (20 mg/day for 2 months) may improve cognitive function in stroke patients with mild cognitive impairment, as measured by MMSE scores and association tests (PMID: 22500312). EEG studies in patients with post-traumatic or vascular brain injury show nootropic-consistent changes including increased alpha/beta rhythms and reduced delta rhythms, with more pronounced effects in vascular disease (PMID: 19008801). Preclinical data suggest neuroprotective properties including protection against glutamate toxicity in hippocampal neurons (PMID: 27265136) and DNA damage prevention in prediabetic mice (PMID: 31776952), but these findings have not been confirmed in human trials.

Source: auto-research

Effective Dose

20 mg daily (clinical studies); animal studies used 0.5 mg/kg IP